focus -WSS

focus

author：focus 2025-09-27 23:31:56 - browse：74

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Stanford president to resign after investigation of research

WSS

Why some people catch Covid but never get sick

Wegovy leads to weight loss. Can it treat depression, too?

States increasingly look to regulate hospital facility fees

Seattle police shoot person suspected in downtown stabbing

Medical experts are missing from AI regulatory conversations

Humana’s losses in Medicare Advantage tank its stock

leisure time

focus

knowledge

Psychedelics group wrestles with new pharma identity

Why you shouldn’t ask, “What country has the best health care?”

The high cost of giving birth even with insurance

White House pharmacy plagued with problems, investigation finds

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare drug price negotiation legal challenge met with skepticism

Hollywood unions extend contract negotiations for actors

New clues to why women have higher risk of autoimmune disorders

Medical records are filled with copy

Trump got a 'target letter.' What is one and what does it mean?

entertainment

Investment in vaccine development is lagging, report finds

India sets sights on home

Reconstructing family trees of blood cells may help predict disease

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Ebola public health emergency is over, WHO declares

Lindsay Lohan welcomes 1st child with husband Bader Shammas

knowledge

hotspot

Wikipedia

focus